These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8175973)

  • 21. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
    Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
    J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus.
    Richter WO; Donner MG; Schwandt P
    J Clin Apher; 1997; 12(4):196-9. PubMed ID: 9483183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea.
    Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y
    Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes.
    Seidel DK; Geiss HC; Donner MG; Ritter MM; Schwandt P; Koll RA; Standl E; Ziegler AG
    J Autoimmun; 1998 Jun; 11(3):273-7. PubMed ID: 9693976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
    Roll U; Christie MR; Standl E; Ziegler AG
    Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes.
    Borg H; Marcus C; Sjöblad S; Fernlund P; Sundkvist G
    Acta Paediatr; 2000 Jan; 89(1):46-51. PubMed ID: 10677057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in relation to residual insulin secretion in children with IDDM.
    Ludvigsson J; Hellström S
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
    Willis JA; Scott RS; Brown LJ; Forbes LV; Schmidli RS; Zimmet PZ; MacKay IR; Rowley MJ
    Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment.
    Hallengren B; Falorni A; Landin-Olsson M; Lernmark A; Papadopoulos KI; Sundkvist G
    J Intern Med; 1996 Jan; 239(1):63-8. PubMed ID: 8551202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus.
    Schott M; Schatz D; Atkinson M; Krischer J; Mehta H; Vold B; Maclaren N
    J Autoimmun; 1994 Dec; 7(6):865-72. PubMed ID: 7888042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years.
    Wroblewski M; Gottsater A; Lindgarde F; Fernlund P; Sundkvist G
    Diabetes Care; 1998 Feb; 21(2):250-5. PubMed ID: 9539991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of islet cell and islet cell surface antibodies to the presentation and early course of IDDM in childhood.
    Daneman D; Sochett E; Pak CY; Yoon JW
    Diabetes Res Clin Pract; 1988 Jan; 4(2):127-32. PubMed ID: 3277828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
    Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
    Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.
    Grubin CE; Daniels T; Toivola B; Landin-Olsson M; Hagopian WA; Li L; Karlsen AE; Boel E; Michelsen B; Lernmark A
    Diabetologia; 1994 Apr; 37(4):344-50. PubMed ID: 8063033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.